FI955587A - Kemialliset yhdisteet - Google Patents

Kemialliset yhdisteet Download PDF

Info

Publication number
FI955587A
FI955587A FI955587A FI955587A FI955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A
Authority
FI
Finland
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
FI955587A
Other languages
English (en)
Swedish (sv)
Other versions
FI955587A0 (fi
Inventor
Peter Clive Cherry
John Derek Cocker
Andrew David Searle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI955587A0 publication Critical patent/FI955587A0/fi
Publication of FI955587A publication Critical patent/FI955587A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FI955587A 1993-05-21 1995-11-20 Kemialliset yhdisteet FI955587A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds
PCT/EP1994/001613 WO1994027989A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity

Publications (2)

Publication Number Publication Date
FI955587A0 FI955587A0 (fi) 1995-11-20
FI955587A true FI955587A (fi) 1995-11-20

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955587A FI955587A (fi) 1993-05-21 1995-11-20 Kemialliset yhdisteet

Country Status (19)

Country Link
EP (1) EP0699196A1 (fi)
JP (1) JPH08510455A (fi)
CN (1) CN1126473A (fi)
AU (1) AU6928794A (fi)
BG (1) BG100154A (fi)
CA (1) CA2162921A1 (fi)
CZ (1) CZ305195A3 (fi)
FI (1) FI955587A (fi)
GB (1) GB9310635D0 (fi)
HU (1) HUT73790A (fi)
IL (1) IL109703A0 (fi)
NO (1) NO954681D0 (fi)
OA (1) OA10195A (fi)
PE (1) PE31195A1 (fi)
PL (1) PL311702A1 (fi)
SK (1) SK142495A3 (fi)
TW (1) TW279866B (fi)
WO (1) WO1994027989A1 (fi)
ZA (1) ZA943494B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0721943A4 (en) * 1993-09-30 1996-09-04 Yamanouchi Pharma Co Ltd AZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
AU3846395A (en) * 1994-11-07 1996-05-31 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
KR19980702319A (ko) * 1995-03-01 1998-07-15 오노다 마사요시 이미다졸 유도체 및 이의 의약 조성물
EP0974584B1 (en) * 1997-02-21 2003-01-15 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
AU2002214296C1 (en) 2000-11-17 2006-04-13 Takeda Pharmaceutical Company Limited Novel imidazole derivatives, production method thereof and use thereof
AU2002214320A1 (en) 2000-11-20 2002-05-27 Takeda Chemical Industries Ltd. Imidazole derivatives, process for their preparation and their use
WO2002046186A1 (fr) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Dérivés thiazole substitués porteurs de groupes 3-pyridyl, procédé d'élaboration et leur utilisation
MX2007015905A (es) * 2005-06-24 2008-03-06 Lilly Co Eli Derivados de tetrahidrocarbazol utiles como moduladores de receptor de androgeno (sarm).
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
GB0525323D0 (en) 2005-12-13 2006-01-18 Sterix Ltd Compound
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
UA105794C2 (uk) 2009-06-26 2014-06-25 Новартіс Аг 1,3-ДИЗАМІЩЕНІ ПОХІДНІ ІМІДАЗОЛІДИН-2-ОНУ ЯК ІНГІБІТОРИ Cyp17
MX338831B (es) 2010-02-04 2016-05-03 Radius Health Inc Moduladores selectivos de receptores de androgenos.
PT2568806T (pt) 2010-05-12 2016-08-05 Radius Health Inc Regimes terapêuticos
KR101823275B1 (ko) 2010-08-04 2018-03-08 펠피큐어 파마슈티걸즈 아이엔씨 전립선 암종의 치료를 위한 병용 요법
WO2012035078A1 (en) 2010-09-16 2012-03-22 Novartis Ag 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
WO2012047617A1 (en) 2010-09-28 2012-04-12 Radius Health, Inc. Selective androgen receptor modulators
WO2012149413A1 (en) 2011-04-28 2012-11-01 Novartis Ag 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
WO2014158875A1 (en) 2013-03-14 2014-10-02 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
FI3122426T3 (fi) 2014-03-28 2023-03-31 Univ Duke Rintasyövän hoitaminen käyttäen selektiivisiä estrogeenin reseptorin modulaattoreita
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
US10093620B2 (en) 2014-09-12 2018-10-09 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
EP4066827A1 (en) 2016-06-22 2022-10-05 Ellipses Pharma Ltd Ar+ breast cancer treatment methods
CA3044812A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione
EP3565542B1 (en) 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
EP0699196A1 (en) 1996-03-06
CA2162921A1 (en) 1994-12-08
GB9310635D0 (en) 1993-07-07
CZ305195A3 (en) 1996-06-12
FI955587A0 (fi) 1995-11-20
OA10195A (en) 1996-12-18
PL311702A1 (en) 1996-03-04
HU9503321D0 (en) 1996-01-29
IL109703A0 (en) 1994-08-26
HUT73790A (en) 1996-09-30
AU6928794A (en) 1994-12-20
NO954681L (no) 1995-11-20
SK142495A3 (en) 1996-06-05
PE31195A1 (es) 1995-10-18
ZA943494B (en) 1995-01-23
NO954681D0 (no) 1995-11-20
BG100154A (en) 1996-07-31
WO1994027989A1 (en) 1994-12-08
JPH08510455A (ja) 1996-11-05
CN1126473A (zh) 1996-07-10
TW279866B (fi) 1996-07-01

Similar Documents

Publication Publication Date Title
FI955587A (fi) Kemialliset yhdisteet
MX9101375A (es) Compuestos quimicos
FI922424A (fi) Kemiska foereningar
BR1101108A (pt) Composto
ID15985A (id) Senyawa kimia
MX9202262A (es) Compuestos quimicos.
DK72693D0 (da) Compounds
NO951433D0 (no) Kjemiske forbindelser
FI945907A0 (fi) Kemiallisia yhdisteitä
FI932571A0 (fi) Kemisk process
DK124393D0 (da) Compounds
FI944825A0 (fi) Fenyylibentsoamidipohjaiset fungsidiyhdisteet
DE59409946D1 (de) Antidröhnmassen.
FI961520A (fi) Heribisidiset atsabisfosfonihappoyhdisteet
KR970707090A (ko) 18-노르-비타민 D 화합물(18-Nor-Vitamin D Compounds)
MX9205851A (es) Compuestos quimicos
NO962264D0 (no) Kjemiske forbindelser
FI954399A (fi) Kemiallinen prosessi
DK244090D0 (da) Kemiske forbindelser
ITRM940566A0 (it) Composti organici
DK150591D0 (da) Kemisk forbindelse
DK85393D0 (da) Kemisk forbindelse
DK39992D0 (da) Kemiske forbindelser
DK102693D0 (da) Novel compounds
KR950013225U (ko) 약탕 증류기

Legal Events

Date Code Title Description
FD Application lapsed